There has been a lot of excitement since the launch. Not only is the drug extremely effective (people lose about 15 percent ...
BioSciences announced new data demonstrating its gene therapy for osteoarthritis candidate, PCRX-201, provided sustained ...
Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback